A Single-Arm, Open-Label, Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Latest Information Update: 28 Aug 2023
At a glance
- Drugs SHR-1918 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Beijing Suncadia Pharmaceuticals
Most Recent Events
- 28 Aug 2023 New trial record